Brief: Cidara Therapeutics Presents Promising New Data On Novel Drug-FC Conjugate Candidates At The American Association For Cancer Research (AACR) Annual Meeting 2024

Cidara Therapeutics

05/04/2024 22:50

April 5 (Reuters) - Cidara Therapeutics Inc  CDTX.O :
    * CIDARA THERAPEUTICS PRESENTS PROMISING NEW DATA ON NOVEL
DRUG-FC
CONJUGATE CANDIDATES AT THE AMERICAN ASSOCIATION FOR CANCER
RESEARCH (AACR) ANNUAL MEETING 2024
    * CIDARA THERAPEUTICS INC - MULTISPECIFIC CD73/PD-1 DFC
DEMONSTRATES IMPROVED TUMOR REDUCTION COMPARED TO PD-1
MONOTHERAPY IN NONCLINICAL STUDY
    * CIDARA THERAPEUTICS INC - LATE-BREAKING CBO421 DATA SHOWS
IMPROVED EFFICACY COMPARED TO OLECLUMAB IN HUMAN TRIPLE-NEGATIVE
BREAST CANCER CELL LINES
    * CIDARA THERAPEUTICS INC - CCR5-TARGETING DFC DEMONSTRATES
POTENT
EFFICACY IN COLORECTAL CANCER MOUSE MODEL

Source text for Eikon:  ID:nGNX78MtXT 
Further company coverage:  CDTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))